Title: Non-cytotoxic radiosensitizers in brain radiotherapy: journey till the first decade of this millennium.
Journal: Current cancer drug targets 20120301
Title: Transport processes of radiopharmaceuticals and -modulators.
Journal: Radiation oncology (London, England) 20110101
Title: Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20100301
Title: The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.
Journal: Journal of neuro-oncology 20100101
Title: Whole brain radiotherapy with radiosensitizer for brain metastases.
Journal: Journal of experimental & clinical cancer research : CR 20090101
Title: Role of palliative radiotherapy in brain metastases.
Journal: Indian journal of palliative care 20090101
Title: Quality of life in brain metastases radiation trials: a literature review.
Journal: Current oncology (Toronto, Ont.) 20081001
Title: Reduction in hemoglobin-oxygen affinity results in the improvement of exercise capacity in mice with chronic heart failure.
Journal: Journal of the American College of Cardiology 20080826
Title: Trimethylaluminium mediated amide bond formation in a continuous flow microreactor as key to the synthesis of rimonabant and efaproxiral.
Journal: Chemical communications (Cambridge, England) 20080307
Title: Neuropsychological testing and biomarkers in the management of brain metastases.
Journal: Radiation oncology (London, England) 20080101
Title: Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.
Journal: American journal of clinical oncology 20071201
Title: The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in mice.
Journal: Radiation research 20070801
Title: Using exposure-response and biomarkers to streamline early drug development.
Journal: Ernst Schering Research Foundation workshop 20070101
Title: Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Journal: BMC cancer 20070101
Title: Current therapeutic approaches in patients with brain metastases.
Journal: Current treatment options in oncology 20061101
Title: Cerebral metastases--a therapeutic update.
Journal: Nature clinical practice. Neurology 20060801
Title: Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases.
Journal: British journal of cancer 20060619
Title: Role of efaproxiral in metastatic brain tumors.
Journal: Expert review of anticancer therapy 20060401
Title: Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival.
Journal: International journal of radiation oncology, biology, physics 20060315
Title: Mass spectrometric characterization of efaproxiral (RSR13) and its implementation into doping controls using liquid chromatography-atmospheric pressure ionization-tandem mass spectrometry.
Journal: Journal of mass spectrometry : JMS 20060301
Title: Efaproxiral (RSR13) plus oxygen breathing increases the therapeutic ratio of carboplatin in EMT6 mouse mammary tumors.
Journal: Experimental biology and medicine (Maywood, N.J.) 20060301
Title: Radiation sensitization with redox modulators: a promising approach.
Journal: International journal of radiation oncology, biology, physics 20060201
Title: New hope for old drug in patients with brain metastases.
Journal: The Lancet. Oncology 20060201
Title: Efaproxiral: should we hold our breath?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060101
Title: Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060101
Title: Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors.
Journal: Radiation oncology (London, England) 20060101
Title: Blood doping by cobalt. Should we measure cobalt in athletes?
Journal: Journal of occupational medicine and toxicology (London, England) 20060101
Title: Efaproxiral: a radiation enhancer used in brain metastases from breast cancer.
Journal: The Annals of pharmacotherapy 20051201
Title: Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901
Title: Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study.
Journal: International journal of radiation oncology, biology, physics 20050401
Title: Hit to Lead Success Stories--IBC Conference: Effective chemistry strategies for reducing attrition rates and speeding lead compounds into the pipeline. 31 January-1 February 2005, San Diego, CA, USA.
Journal: IDrugs : the investigational drugs journal 20050301
Title: R-state hemoglobin bound to heterotropic effectors: models of the DPG, IHP and RSR13 binding sites.
Journal: FEBS letters 20050131
Title: Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Journal: Drugs in R&D 20050101
Title: Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
Journal: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20050101
Title: Modeling of the response of ptO2 in rat brain to changes in physiological parameters.
Journal: Advances in experimental medicine and biology 20050101
Title: Novel radiosensitizers for tumors of the central nervous system.
Journal: Current opinion in investigational drugs (London, England : 2000) 20041201
Title: Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
Journal: International journal of radiation oncology, biology, physics 20040701
Title: Efaproxiral: a novel radiation sensitiser.
Journal: Expert opinion on investigational drugs 20040501
Title: Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Journal: Cancer chemotherapy and pharmacology 20040101
Title: Efaproxiral (Allos Therapeutics).
Journal: IDrugs : the investigational drugs journal 20030801
Title: RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615
Title: Allosteric modification of hemoglobin by RSR13 as a therapeutic strategy.
Journal: Advances in experimental medicine and biology 20030101
Title: The dose-dependent effect of RSR13, a synthetic allosteric modifier of hemoglobin, on physiological parameters and brain tissue oxygenation in rats.
Journal: Advances in experimental medicine and biology 20030101
Title: The effect of RSR13, a synthetic allosteric modifier of hemoglobin, on brain tissue pO2 (measured by EPR oximetry) following severe hemorrhagic shock in rats.
Journal: Advances in experimental medicine and biology 20030101
Title: [Blood doping and cardiovascular consequences].
Journal: Presse medicale (Paris, France : 1983) 20021221
Title: Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020715
Title: Increasing P(50) does not improve DO(2CRIT) or systemic VO(2) in severe anemia.
Journal: American journal of physiology. Heart and circulatory physiology 20020701
Title: Pharmacological correction of hypothermic P(50) shift does not alter outcome from focal cerebral ischemia in rats.
Journal: American journal of physiology. Heart and circulatory physiology 20020501
Title: Synthesis and X-ray studies of chiral allosteric modifiers of hemoglobin.
Journal: Journal of medicinal chemistry 20020314
Title: Effects of enhanced oxygen release from hemoglobin by RSR13 in an acute renal failure model.
Journal: Kidney international 20011001
Title: Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13.
Journal: Radiation research 20010901
Title: High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector.
Journal: Protein science : a publication of the Protein Society 20010501
Title: A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics.
Journal: International journal of radiation oncology, biology, physics 20010315
Title: Allosteric modification of oxygen delivery by hemoglobin.
Journal: Anesthesia and analgesia 20010301
Title: RSR13, a potential athletic performance enhancement agent: detection in urine by gas chromatography/mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20010101
Title: Stea B, et al. Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases. Br J Cancer. 2006 Jun 19;94(12):1777-1784.
Title: Abraham DJ, et al. Allosteric modifiers of hemoglobin: 2--[[(3,5-disubstituted anilino)carbonylmethylphenoxy-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry. 1992 Sep 29;31(38):9141-9.
Title: Hou H, et al. The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in mice. Radiat Res. 2007 Aug;168(2):218-25.
Title: Hou H, et al. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1503-9.
